Search for a doctor

Jean-Claude M. Rwigema, M.D.

  1. Radiation Oncologist
Request an Appointment

Publications

  1. Foote RL, Harmsen WS, Amundson AC, Carr AB, Gamez ME, Garces YI, Lester SC, Ma DJ, McGee LA, Moore EJ, Neben Wittich MA, Patel SH, Routman DM, Rwigema JM, Van Abel KM, Yin LX, Muller OM, Shiraishi S. Mean Oral Cavity Organ-at-Risk Dose Predicts Opioid Use and Hospitalization during Radiotherapy for Patients with Head and Neck Tumors. Cancers (Basel). 2024 Jan 13; 16 (2)
    View PubMed
  2. Garcia DA, Jeans EB, Morris LK, Shiraishi S, Laughlin BS, Rong Y, Rwigema JM, Foote RL, Herman MG, Qian J. A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy. Cancers (Basel). 2023 Jul 22; 15 (14) Epub 2023 July 22
    View PubMed
  3. Laughlin BS, Ebrahimi S, Voss MM, Patel SH, Foote RL, McGee LA, Garcia J, Ma DJ, Garces YI, Wittich MAN, Price KA, Schmitt A, Zhai Q, May BC, Nagel TH, Hinni ML, Chintakuntlawar AV, DeWees TA, Rwigema JM. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience. Adv Radiat Oncol. 2023 Jul-Aug; 8 (4):101204 Epub 2023 Mar 01
    View PubMed
  4. Laughlin BS, Thorpe CS, DeWees TA, Voss MM, Chang JH, Hartsell WF, Sinesi CC, Rwigema JM, Keole SR, Gondi V, Vargas CE. Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003. Adv Radiat Oncol. 2023 May-Jun; 8 (3):101142 Epub 2022 Dec 09
    View PubMed
  5. Laughlin BS, Voss MM, Toesca DAS, Daniels T, Golafshar MA, Keole SR, Wong WW, Rwigema JC, Davis B, Schild SE, Stish BJ, Choo R, Lester S, DeWees TA, Vargas CE. Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy. Adv Radiat Oncol. 2023 Mar-Apr; 8 (2):101143 Epub 2022 Dec 10
    View PubMed
  6. Hobbis D, Yu NY, Mund KW, Duan J, Rwigema JM, Wong WW, Schild SE, Keole SR, Feng X, Chen Q, Vargas CE, Rong Y. First Report On Physician Assessment and Clinical Acceptability of Custom-Retrained Artificial Intelligence Models for Clinical Target Volume and Organs-at-Risk Auto-Delineation for Postprostatectomy Patients. Pract Radiat Oncol. 2023 Jul-Aug; 13(4):351-362. Epub 2023 Apr 06.
    View PubMed
  7. Laughlin BS, Narang GL, Cheney SM, Humphreys MR, Vargas CE, Keole SR, Rwigema JM, Schild SE, Wong WW. Toxicity and outcomes after external beam irradiation for prostate cancer in patients with prior holmium laser enucleation of the prostate: Early experience. Cancer Rep (Hoboken). 2023 Jan; 6 (1):e1672 Epub 2022 July 05
    View PubMed
  8. Laughlin BS, Yu NY, Lo S, Duan J, Welchel Z, Tinnon K, Beckett M, Schild SE, Wong WW, Keole SR, Rwigema JM, Vargas CE, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance. Cancers (Basel). 2022 Dec 21; 15 (1)
    View PubMed
  9. Laughlin BS, Lo S, Vargas CE, DeWees TA, Van der Walt C, Tinnon K, Beckett M, Hobbis D, Schild SE, Wong WW, Keole SR, Rwigema JM, Yu NY, Clouser E, Rong Y. Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 1: Consistent Organs at Risk Management with Advanced Image Guidance. Cancers (Basel). 2022 Dec 20; 15 (1)
    View PubMed
  10. Yang Y, Rwigema JM, Vargas C, Yu NY, Keole SR, Wong WW, Schild SE, Bues M, Liu W, Shen J. Technical note: Investigation of dose and LET(d) effect to rectum and bladder by using non-straight laterals in prostate cancer receiving proton therapy. Med Phys. 2022 Dec; 49 (12):7428-7437 Epub 2022 Oct 18
    View PubMed
  11. Yang Y, Patel SH, Bridhikitti J, Wong WW, Halyard MY, McGee LA, Rwigema JM, Schild SE, Vora SA, Liu T, Bues M, Fatyga M, Foote RL, Liu W. Exploratory study of seed spots analysis to characterize dose and linear-energy-transfer effect in adverse event initialization of pencil-beam-scanning proton therapy. Med Phys. 2022 Sep; 49 (9):6237-6252 Epub 2022 July 21
    View PubMed
  12. Bhangoo RS, Petersen MM, Bulman GF, Vargas CE, Thorpe CS, Shen J, Wong WW, Rwigema JM, Daniels TB, Keole SR, Schild SE, Rong Y, DeWees TA. Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer. Int J Part Ther. 2022 Spring; 8 (4):37-46 Epub 2021 Sept 08
    View PubMed
  13. Jeans EB, Shiraishi S, Manzar G, Morris LK, Amundson A, McGee LA, Rwigema JC, Neben-Wittich M, Routman DM, Ma DJ, Patel SH, Foote RL, Lester SC. An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers. Head Neck. 2022 Feb; 44 (2):359-371 Epub 2021 Dec 03
    View PubMed
  14. Yang Y, Muller OM, Shiraishi S, Harper M, Amundson AC, Wong WW, McGee LA, Rwigema JM, Schild SE, Bues M, Fatyga M, Anderson JD, Patel SH, Foote RL, Liu W. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated With Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study. Front Oncol. 2022; 12:843175 Epub 2022 Mar 03
    View PubMed
  15. Kowalchuk RO, Hillman D, Daniels TB, Vargas CE, Rwigema JM, Wong WW, Stish BJ, Dueck AC, Choo R. Assessing concordance between patient-reported and investigator-reported CTCAE after proton beam therapy for prostate cancer. Clin Transl Radiat Oncol. 2021 Nov; 31:34-41 Epub 2021 Sept 15
    View PubMed
  16. Choo R, Hillman DW, Daniels T, Vargas C, Rwigema JC, Corbin K, Keole S, Vora S, Merrell K, Stish B, Pisansky T, Davis B, Amundson A, Wong W. Proton Therapy of Prostate and Pelvic Lymph Nodes for High Risk Prostate Cancer: Acute Toxicity. Int J Part Ther. 2021 Fall; 8 (2):41-50 Epub 2021 Sept 14
    View PubMed
  17. Yang Y, Vargas CE, Bhangoo RS, Wong WW, Schild SE, Daniels TB, Keole SR, Rwigema JM, Glass JL, Shen J, DeWees TA, Liu T, Bues M, Fatyga M, Liu W. Exploratory Investigation of Dose-Linear Energy Transfer (LET) Volume Histogram (DLVH) for Adverse Events Study in Intensity Modulated Proton Therapy (IMPT). Int J Radiat Oncol Biol Phys. 2021 Jul 15; 110 (4):1189-1199 Epub 2021 Feb 20
    View PubMed
  18. Gamez ME, Patel SH, McGee LA, Sio TT, McDonald M, Phan J, Ma DJ, Foote RL, Rwigema JM. A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors. Int J Part Ther. 2021 Summer; 8 (1):131-154 Epub 2021 June 25
    View PubMed
  19. Bridhikitti J, Viehman JK, Harmsen WS, Amundson AC, Shiraishi S, Mundy DW, Rwigema JM, McGee LA, Patel SH, Routman DM, Lester SC, Neben-Wittich MA, Garces YI, Ma DJ, Foote RL. Oncologic Outcomes for Head and Neck Skin Malignancies Treated with Protons. Int J Part Ther. 2021 Summer; 8 (1):294-303 Epub 2021 June 25
    View PubMed
  20. Yu NY, Khurana A, Ma DJ, Neben-Wittich MA, Golafshar MA, McGee LA, Rwigema JM, Foote RL, Patel SH. Initial Experience with Proton Beam Therapy for Differentiated Thyroid Cancer. Int J Part Ther. 2021 Summer; 8 (1):311-318 Epub 2021 June 25
    View PubMed
  21. Evans JD, Harper RH, Petersen M, Harmsen WS, Anand A, Hunzeker A, Deiter NC, Schultz H, Jethwa KR, Lester SC, Routman DM, Ma DJ, Garces YI, Neben-Wittich MA, Laack NN, Beltran CJ, Patel SH, McGee LA, Rwigema JC, Mundy DW, Foote RL. The importance of verification CT-QA scans in patients treated with IMPT for head and neck cancers. Int J Part Ther. 2020 Aug; 7(1):41-53.
  22. Pan X, Zhang T, Yang Q, Yang D, Rwigema JC, Qi XS. Survival prediction for oral tongue cancer patients via probabilistic genetic algorithm optimized neural network models. Br J Radiol. 2020 Aug; 93 (1112):20190825 Epub 2020 June 19
    View PubMed
  23. Evans JD, Harper RH, Petersen M, Harmsen WS, Anand A, Hunzeker A, Deiter NC, Schultz H, Jethwa KR, Lester SC, Routman DM, Ma DJ, Garces YI, Neben-Wittich MA, Laack NN, Beltran CJ, Patel SH, McGee LA, Rwigema JM, Mundy DW, Foote RL. The Importance of Verification CT-QA Scans in Patients Treated with IMPT for Head and Neck Cancers. Int J Part Ther. 2020 Summer; 7 (1):41-53 Epub 2020 Aug 03
    View PubMed
  24. Yu NY, DeWees TA, Liu C, Daniels TB, Ashman JB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Rwigema JM, Ding JX, Shan J, Liu W, Schild SE, Sio TT. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience. Adv Radiat Oncol. 2020 May-Jun; 5 (3):450-458 Epub 2019 Aug 21
    View PubMed
  25. Sio TT, Blanchard MJ, Novotny PJ, Patel SH, Rwigema JM, Pederson LD, McGee LA, Gamez ME, Seeger GR, Martenson JA, Grover Y, Neben Wittich MA, Garces YI, Foote RL, Miller RC, Halyard MY. N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial. Mayo Clin Proc. 2019 Sep; 94 (9):1814-1824 Epub 2019 Aug 09
    View PubMed
  26. Rwigema JM, Langendijk JA, Paul van der Laan H, Lukens JN, Swisher-McClure SD, Lin A. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2019 Jul 1; 104 (3):553-562 Epub 2019 Jan 06
    View PubMed
  27. Sio TT, Atherton PJ, Pederson LD, Zhen WK, Mutter RW, Garces YI, Ma DJ, Leenstra JL, Rwigema JM, Dakhil S, Bearden JD, van der Veen SJ, Ganti AK, Schild SE, Miller RC. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Int J Radiat Oncol Biol Phys. 2019 Mar 1; 103 (3):686-696 Epub 2018 Nov 02
    View PubMed
  28. Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, Rwigema JCM, McGee LA, Halyard MY, Buras MR, Foote RL, Patel SH. Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults. Oral Oncol. 2018 Dec; 87:43-48 Epub 2018 Oct 22
    View PubMed
  29. Haefner MF, Verma V, Bougatf N, Mielke T, Tonndorf-Martini E, Konig L, Rwigema JM, Simone CB 2nd, Uhlmann L, Eichhorn F, Winter H, Grosch H, Haberer T, Herfarth K, Debus J, Rieken S. Dosimetric comparison of advanced radiotherapy approaches using photon techniques and particle therapy in the postoperative management of thymoma. Acta Oncol. 2018 Dec; 57 (12):1713-1720 Epub 2018 Sept 28
    View PubMed
  30. Odei B, Rwigema JC, Eilber FR, Eilber FC, Selch M, Singh A, Chmielowski B, Nelson SD, Wang PC, Steinberg M, Kamrava M. Predictors of Local Recurrence in Patients With Myxofibrosarcoma. Am J Clin Oncol. 2018 Sep; 41 (9):827-831
    View PubMed
  31. Kishan AU, Duchesne G, Wang PC, Rwigema JM, Kishan AU, Saigal C, Rettig M, Steinberg ML, King CR. Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer. Am J Clin Oncol. 2018 Aug; 41 (8):739-746
    View PubMed
  32. Vahabzadeh-Hagh AM, Rwigema JM, Nabili V, Wang MB, Lorentz WC. Predictors of prolongation in radiation treatment time in a veteran population treated with chemoradiation for oropharyngeal cancer. Acta Otolaryngol. 2018 Jan; 138 (1):80-84 Epub 2017 Sept 12
    View PubMed
  33. Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer. Cancer. 2017 Nov 1; 123 (21):4244-4251 Epub 2017 July 05
    View PubMed
  34. Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB 2nd. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Radiother Oncol. 2017 Oct; 125 (1):21-30 Epub 2017 Sept 20
    View PubMed
  35. Verma V, Rwigema JM, Adeberg S, Simone CB 2nd. Enrollment of Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer in Multi-institutional Trials of Proton Beam Radiation Therapy. Clin Lung Cancer. 2017 Sep; 18 (5):441-443 Epub 2017 Mar 16
    View PubMed
  36. Rwigema JM, Choi J, Lee NY, Heron DE, Chen AM. Re-Irradiation Therapy for Locally Recurrent Head and Neck Cancer: A National Survey of Practice Patterns. Cancer Invest. 2017 Jul 3; 35 (6):393-402 Epub 2017 Apr 24
    View PubMed
  37. Kishan AU, Duchesne G, Wang P-C, Rwigema J, Saigal C, Rettig M, Steinberg ML, King CR. Specialty biases influence recommended treatment strategies for patients with high-risk prostate cancer: a patterns of care study Am J Clin Oncol. 2017 Jul; 35(6):393-402.
  38. Rwigema JM, Lamiman K, Reznik RS, Lee NJH, Olch A, Wong KK. Palliative radiation therapy for superior vena cava syndrome in metastatic Wilms tumor using 10XFFF and 3D surface imaging to avoid anesthesia in a pediatric patient-a teaching case. Adv Radiat Oncol. 2017 Jan-Mar; 2 (1):101-104 Epub 2017 Jan 07
    View PubMed
  39. Verma V, Shah C, Rwigema JC, Solberg T, Zhu X, Simone CB 2nd. Cost-comparativeness of proton versus photon therapy. Chin Clin Oncol. 2016 Aug; 5 (4):56 Epub 2016 July 27
    View PubMed
  40. Gou S, Lee P, Hu P, Rwigema JC, Sheng K. Feasibility of automated 3-dimensional magnetic resonance imaging pancreas segmentation. Adv Radiat Oncol. 2016 Jul-Sep; 1 (3):182-193 Epub 2016 May 30
    View PubMed
  41. Merna C, Rwigema JC, Cao M, Wang PC, Kishan AU, Michailian A, Lamb J, Sheng K, Agazaryan N, Low DA, Kupelian P, Steinberg ML, Lee P. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer. Med Dosim. 2016 Spring; 41 (1):87-91 Epub 2016 Jan 02
    View PubMed
  42. Rwigema J, Vargo JA, Clump DA, Ferris RL, Ohr J, Heron DE. Stereotactic Body Radiotherapy in the Management of Head and Neck Malignancies. Current Cancer Therapy Reviews.2016;12:(4):314-22.
  43. Rwigema JC, Lee P. Is staging mediastinoscopy necessary before stereotactic body radiotherapy for inoperable early stage lung cancer? J Thorac Dis. 2015 Dec; 7 (12):E612-4
    View PubMed
  44. Kishan AU, Cao M, Wang PC, Mikaeilian AG, Tenn S, Rwigema JM, Sheng K, Low DA, Kupelian PA, Steinberg ML, Lee P. Feasibility of magnetic resonance imaging-guided liver stereotactic body radiation therapy: A comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based intensity modulated radiation therapy. Pract Radiat Oncol. 2015 Sep-Oct; 5 (5):330-337 Epub 2015 Mar 29
    View PubMed
  45. Wegner RE, Leeman JE, Kabolizadeh P, Rwigema JC, Mintz AH, Burton SA, Heron DE. Fractionated stereotactic radiosurgery for large brain metastases. Am J Clin Oncol. 2015 Apr; 38: (2)135-9.
    View PubMed
  46. Rwigema JC, Nguyen D, Heron DE, Chen AM, Lee P, Wang PC, Vargo JA, Low DA, Huq MS, Tenn S, Steinberg ML, Kupelian P, Sheng K. 4pi noncoplanar stereotactic body radiation therapy for head-and-neck cancer: potential to improve tumor control and late toxicity. Int J Radiat Oncol Biol Phys. 2015 Feb 1; 91 (2):401-9 Epub 2014 Dec 05
    View PubMed
  47. Nguyen D, Rwigema JC, Yu VY, Kaprealian T, Kupelian P, Selch M, Lee P, Low DA, Sheng K. Feasibility of extreme dose escalation for glioblastoma multiforme using 4pi radiotherapy. Radiat Oncol. 2014 Nov 7; 9:239 Epub 2014 Nov 07
    View PubMed
  48. Vargo JA, Heron DE, Ferris RL, Rwigema JC, Kalash R, Wegner RE, Ohr J, Burton S. Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: implications of treatment duration and tumor volume. Head Neck. 2014 Sep; 36 (9):1349-55 Epub 2014 Jan 13
    View PubMed
  49. Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy. Clin Lung Cancer. 2014 Jul; 15 (4):287-93 Epub 2014 Feb 04
    View PubMed
  50. Kamrava M, Rwigema JC, Chung M, Banerjee R, Wang J, Steinberg M, Demanes DJ. Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer. J Contemp Brachytherapy. 2013 Sep; 5: (3)127-33.
    View PubMed
  51. Wang K, Heron DE, Clump DA, Flickinger JC, Kubicek GJ, Rwigema JC, Ferris RL, Ohr JP, Quinn AE, Ozhasoglu C, Branstetter BF. Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation. Radiother Oncol. 2013 Jan; 106 (1):90-5 Epub 2013 Jan 17
    View PubMed
  52. Vargo JA, Wegner RE, Heron DE, Ferris RL, Rwigema JC, Quinn A, Gigliotti P, Ohr J, Kubicek GJ, Burton S. Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck. Head Neck. 2012 Aug; 34 (8):1153-61 Epub 2011 Nov 11
    View PubMed
  53. Olson AC, Wegner RE, Rwigema J, Heron DE, Burton SA, Mintz AH. Clinical outcomes of reirradiation of brain metastases from small cell lung cancer with Cyberknife stereotactic radiosurgery. J Cancer Res Ther. 2012 Jul-Sep; 8: (3)411-6.
    View PubMed
  54. Vargo JA, Heron DE, Ferris RL, Rwigema JC, Wegner RE, Kalash R, Ohr J, Kubicek GJ, Burton S. Prospective evaluation of patient-reported quality-of-life outcomes following SBRT +/- cetuximab for locally-recurrent, previously-irradiated head and neck cancer. Radiother Oncol. 2012 Jul; 104 (1):91-5 Epub 2012 June 05
    View PubMed
  55. Beriwal S, Rwigema JC, Higgins E, Kim H, Houser C, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012 May-Jun; 11 (3):176-80 Epub 2011 June 12
    View PubMed
  56. Wang K, Heron DE, Flickinger JC, Rwigema JC, Ferris RL, Kubicek GJ, Ohr JP, Quinn AE, Ozhasoglu C, Branstetter BF. A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer. Head Neck Oncol. 2012 Apr 19; 4:12
    View PubMed
  57. Rwigema JC, Heron DE, Parikh SD, Zeh HJ 3rd, Moser JA, Bahary N, Ashby K, Burton SA. Adjuvant stereotactic body radiotherapy for resected pancreatic adenocarcinoma with close or positive margins. J Gastrointest Cancer. 2012 Mar; 43 (1):70-6
    View PubMed
  58. Bernard ME, Kim H, Rajagopalan MS, Stone B, Salimi U, Rwigema JC, Epperly MW, Shen H, Goff JP, Franicola D, Dixon T, Cao S, Zhang X, Wang H, Stolz DB, Greenberger JS. Repopulation of the irradiation damaged lung with bone marrow-derived cells. In Vivo. 2012 Jan-Feb; 26 (1):9-18
    View PubMed
  59. Bernard ME, Kim H, Rwigema JC, Epperly MW, Kelley EE, Murdoch GH, Dixon T, Wang H, Greenberger JS. Role of the esophageal vagus neural pathway in ionizing irradiation-induced seizures in nitric oxide synthase-1 homologous recombinant negative NOS1-/- mice. In Vivo. 2011 Nov-Dec; 25: (6)861-9.
    View PubMed
  60. Defoe SG, Bernard ME, Rwigema JC, Heron DE, Ozhasoglu C, Burton S. Stereotactic body radiotherapy for the treatment of presacral recurrences from rectal cancers. J Cancer Res Ther. 2011 Oct-Dec; 7: (4)408-11.
    View PubMed
  61. Rwigema JC, Heron DE, Ferris RL, Andrade RS, Gibson MK, Yang Y, Ozhasoglu C, Argiris AE, Grandis JR, Burton SA. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol. 2011 Aug; 34 (4):372-9
    View PubMed
  62. Rwigema JC, Beck B, Wang W, Doemling A, Epperly MW, Shields D, Goff JP, Franicola D, Dixon T, Frantz MC, Wipf P, Tyurina Y, Kagan VE, Wang H, Greenberger JS. Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators. Int J Radiat Oncol Biol Phys. 2011 Jul 1; 80 (3):860-8 Epub 2011 Apr 13
    View PubMed
  63. Heron DE, Rwigema JC, Gibson MK, Burton SA, Quinn AE, Ferris RL. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol. 2011 Apr; 34 (2):165-72
    View PubMed
  64. Rwigema JC, Parikh SD, Heron DE, Howell M, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA. Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol. 2011 Feb; 34 (1):63-9
    View PubMed
  65. Rwigema JC, Wegner RE, Mintz AH, Paravati AJ, Burton SA, Ozhasoglu C, Heron DE. Stereotactic radiosurgery to the resection cavity of brain metastases: a retrospective analysis and literature review. Stereotact Funct Neurosurg. 2011; 89 (6):329-37 Epub 2011 Oct 14
    View PubMed
  66. Epperly MW, Goff JP, Li S, Gao X, Wipf P, Dixon T, Wang H, Franicola D, Shen H, Rwigema JC, Kagan V, Bernard M, Greenberger JS. Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis. In Vivo. 2010 Nov-Dec; 24 (6):811-9
    View PubMed
  67. Rajagopalan MS, Stone B, Rwigema JC, Salimi U, Epperly MW, Goff J, Franicola D, Dixon T, Cao S, Zhang X, Buchholz BM, Bauer AJ, Choi S, Bakkenist C, Wang H, Greenberger JS. Intraesophageal manganese superoxide dismutase-plasmid liposomes ameliorates novel total-body and thoracic radiation sensitivity of NOS1-/- mice. Radiat Res. 2010 Sep; 174: (3)297-312.
    View PubMed
  68. Gokhale A, Rwigema JC, Epperly MW, Glowacki J, Wang H, Wipf P, Goff JP, Dixon T, Patrene K, Greenberger JS. Small molecule GS-nitroxide ameliorates ionizing irradiation-induced delay in bone wound healing in a novel murine model. In Vivo. 2010 Jul-Aug; 24: (4)377-85.
    View PubMed
  69. Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, Ozhasoglu C, Burton S. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience. Am J Clin Oncol. 2010 Jun; 33: (3)286-93.
    View PubMed
  70. Epperly MW, Franicola D, Shields D, Rwigema JC, Stone B, Zhang X, McBride W, Georges G, Wipf P, Greenberger JS. Screening of antimicrobial agents for in vitro radiation protection and mitigation capacity, including those used in supportive care regimens for bone marrow transplant recipients. In Vivo. 2010 Jan-Feb; 24: (1)9-19.
    View PubMed
PST-20308665